NFE2L2 and colonic neoplasm: Also, the anti-cancer effects of FMBP were mainly achieved through the accumulation of more ROS in colon cancer cells than normal cells, attributed to the down-regulation of NF-E2-related factor 2 (Nrf2) expression, and the reduction of catalase activities and glutathione contents [45].